Tag: Competition

Displaying 161 - 180 of 1615 results.

Following a public comment period, the Federal Trade Commission has approved a final consent order settling charges that Endo Health Solutions’ acquisition of Boca Life Sciences would likely reduce competition in U.S. markets for seven generic drugs.
From: (Redacted) Sent: Thursday, February 27, 2014 4:46 PM To: Verne, B. Michael; Walsh, Kathryn Subject: Request for Informal Advice regarding Trusts Mike and Kate: I am hoping that you can help me to analyze the HSR implications of two scenarios relating to trusts.
From: (Redacted) Sent: Tuesday, February 04, 2014 12:53 PM To: Verne, B. Michael; Walsh, Kathryn Cc: (Redacted) Subject: 801.1(a)(2) Mike and Kate, We represent a foreign issuer ("Corporation A") that intends to acquire a controlling interest in another foreign issuer in exchange...
January 31, 2014 Mr. B. Michael Verne Ms. Kathryn E. Walsh Premerger Notification Office Bureau of Competition Federal Trade Commission 600 Pennsylvania Avenue, N.W. Washington, DC 20580 Re: Commercial Arrangement Between Company A and Company B Dear Mr. Verne and Ms. Walsh...
From: (Redacted) Sent: Tuesday, January 28, 2014 4:28 PM To: Verne, B. Michael Cc: Walsh, Kathryn Subject: RE: HSR Question Thanks Mike. I have a related question on beneficial ownership but limited to a call option. Assume that the jurisdictional tests are satisfied.
From: (Redacted) Sent: Monday, January 27, 2014 8:47 AM To: Verne, B. Michael Subject: Performance Stock Units Hi Mike. Happy Monday! I have a question about the possible HSR reportability of "performance stock units" ("PSUs") awarded to a company executive {Mr. X).
From: (Redacted) Sent Monday, January 27, 2014 3:35 PM To: Verne, B. Michael Cc: (Redacted) Subject: HSR Question re Exclusive Distribution Dear Mike,
From: (Redacted) Sent: January 22,2014 10:54 AM To: Verne, B. Michael; Walsh, Kathryn Subject: 802.5 pipelines Mike and Kate,
From: (Redacted) Sent: Thursday, January 16, 2014 1:49 PM To: Verne, B. Michael Cc: (Redacted) Subject: Exclusive Pharmaceutical Licenses Mike:
From: (Redacted) Sent: Friday, January 03, 2014 2:33 PM To: Verne, B. Michael Subject: Calculating Percentage of Voting Securities Mike- I am trying to determine the UPE of the acquiring person and would appreciate guidance regarding the calculation of the ·percentage of voting...
From: (Redacted) Sent: Thursday, December 19, 2013 12:44 PM To: Verne, B. Michael; Walsh, Kathryn Subject: SOP/Rollover Shareholders/UPE Question Hi Mike and Kate, This is probably a very easy question for you but I want to confirm the thinking. In this transaction: 1. Fund A, B...
From: (Redacted) Sent: Thursday, December 19, 2013 1:37 PM To: Verne, B. Michael; Walsh, Kathryn Subject: 802.51 For purposes of this rule, if one is signing a deal in January 2014, must one look to 2013 revenues? In some cases they may not be available. I know for item 5, or...
From: (Redacted) Sent: Thursday, December 19, 2013 10:22 AM To: Verne, B. Michael Cc: (Redacted) Subject: HSR Exemption Regarding Timberland Mike, I am writing to confirm my understanding of a telephone conversation with you on December 16, 2013 concerning a basis for non-...
From: (Redacted) Sent: Friday, December 13, 2013 3:08 PM To: Verne, B. Michael; Walsh, Kathryn Cc: (Redacted) Subject: Inquiry Regarding Acquisition by State University Hospital System Mike and Kate: I am writing to you with respect to whether the transaction described below...
From: (Redacted) Sent: Tuesday, December 10, 2013 5:55 PM To: Verne, B. Michael; Walsh, Kathryn Cc: (Redacted) Subject: Question Regarding the Effective Date of New Rule 801.2 Mike and Kate I hope the snow has not been treating you too badly.
From: (Redacted) Sent: Friday, December 06, 2013 10:12 AM To: Verne, B. Michael Subject: Request for HSR Guidance - Section 7A(c)(1),Rule 802.1(a), (d) We seek confirmation that the proposed transaction described below is exempt from the notification and waiting period...
From: (Redacted) Sent: Thursday, December 05, 2013 12:52 PM To: Verne, B. Michael Cc: Walsh, Kathryn; (Redacted) Subject: Questions regarding (1) 801.40 formation analysis for pre-IPO transactions, and (2) "associated exploration and production assets" for purposes of 802.3 Dear...
From: (Redacted) Sent: Wednesday, December 04, 2013 10:30 AM To: Verne, B. Michael Cc: (Redacted) Subject: Request for Confirmation/Clarification of Views Concerning Acquisition of "Exempt" Foreign Issuers and "Non-Exempt" US Issuers Under a Single Agreement -- (Size-of-...
From: Johnson, Janice C Sent: Friday, November 22, 2013 3:44 PM To: (Redacted) (Redacted), in discussions with other staff, I've come up with a different response: Yes, you would include the cash. The parties are adjusting the purchase price to $72 million because they didn't take...

Pages